Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2026)

Kiniksa Pharmaceuticals International has reported Change in Inventory for 6 years, with the latest figure at $18.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 524.82% year-over-year to $18.2 million; the trailing twelve-month figure through Mar 2026 stood at $51.1 million (up 1080.46% YoY), and the FY2025 full-year result was $28.5 million, up 699.64% from the prior year.
• Change in Inventory for Q1 2026 stood at $18.2 million, up from $13.5 million in the prior quarter.
• The five-year high for Change in Inventory was $26.1 million in Q2 2025, with the low at -$6.8 million in Q3 2025.
• Historically, Change in Inventory has averaged $4.1 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2022 — Change in Inventory tumbled 583.23% — and 2024, when it surged 1322.14%.
• Kiniksa Pharmaceuticals International's Change in Inventory stood at $7.0 million in 2022, then decreased by 20.62% to $5.5 million in 2023, then sank by 141.81% to -$2.3 million in 2024, then jumped by 682.86% to $13.5 million in 2025, then surged by 35.17% to $18.2 million in 2026.
• The last three Change in Inventory figures came in at $18.2 million (Q1 2026), $13.5 million (Q4 2025), and -$6.8 million (Q3 2025), per Business Quant data.